Neenah Advances Medical Packaging Category with New Lightweight Reinforced Paper-Based Solution
Neenah, Inc. (NYSE: NP) has launched an ultra-lightweight medical packaging solution that presents a cost-effective alternative to traditional kraft and synthetic options. This new 72 gsm product enhances the company’s existing range, which includes 85 gsm and 112 gsm grades. The packaging is crafted from FSC-controlled fibers and adheres to regulatory sterilization standards. As single-use medical devices become more prevalent for their efficiency and infection control, this innovation positions Neenah to better serve its global supply chain partners and respond to the growing wound care market.
- Launch of an ultra-lightweight 72 gsm medical packaging solution, enhancing product range.
- Product is made from FSC-controlled fibers and complies with sterilization regulations.
- Addresses growing demand in the wound care market, positioning Neenah for growth.
- None.
Neenah, Inc. (NYSE: NP), the leading North American supplier of reinforced medical packaging papers, announces an ultra-lightweight addition to their single-use sterile packaging offering. This innovative, high-performance solution introduces the market to a durable, cost-saving alternative to kraft and synthetic-based medical packaging traditionally used for nasal swabs, syringes, and other single-use applications.
“This ultra-lightweight addition brings new opportunities closer in reach with our global sterile supply chain partners,” says Valerie Henderson, Medical Packaging Product Manager for Neenah.
Single-use medical devices are gaining popularity as they help lower costs, increase efficiency, and reduce the spread of infection. Most single-use devices have a shelf life of 3-5 years, making it imperative that the sterilization process remain intact from supplier to opening at the final destination. Kraft-based medical packaging, used for single-use devices, can tear or burst due to packing or transportation style. It is essential that medical packaging be durable, especially if it is lightweight.
The new ultra-lightweight 72 gsm (grams per square meter) grade joins Neenah’s medical packaging offering that currently includes lightweight 85 gsm and heavyweight 112 gsm options. The entire paper-based product line is manufactured using FSC controlled fibers, compliant with regulatory standards, and accepts steam and Ethylene Oxide (EO) sterilization methods. These products also deliver superior breathable barrier properties, plus excellent conformability and printability.
“Recently, we’ve witnessed extreme and unprecedented growth in the wound care market. With this revolutionary, ultra-lightweight reinforced paper, Neenah is reacting in real-time to help our customers grow and embrace new opportunities. I’m excited to bring this innovative solution to the market,” says Jaime Zohrer, International Sales Development Manager for Neenah.
For purchase or more information on Neenah’s medical packaging offering, please contact your medical packaging source converter.
About Neenah, Inc.
Neenah is committed to manufacturing growth for its customers, end-users, shareholders, and employees. With manufacturing facilities across North America, Europe, and Asia, we are a leading global manufacturer of specialty materials serving customers across six continents, with headquarters in Alpharetta, GA. We are focused on growing in filtration media, specialty coatings, custom-engineered materials, and premium packaging. Our materials are found in a variety of products used every day, such as transportation and water filters, premium packaging of spirits, technology and beauty products, industrial labels, tapes and abrasives, and digital printing for high-end apparel. To learn more, please visit www.neenah.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210527005168/en/
FAQ
What is Neenah's recent product launch?
How does Neenah's new packaging impact the medical industry?
What are the benefits of Neenah's medical packaging?
In what market segment is Neenah seeing growth?